Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CANF will decline by -100.00% over the next 2 Weeks and hit $0.00 by Thursday, February 19, 2026. In that time frame, CANF's share price is expected to range between $0.00 and $0.00.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 19, 2026 | 0.00 | 0.00 | 0.00 |
| Feb 18, 2026 | 0.00 | 0.00 | 0.00 |
| Feb 17, 2026 | 0.00 | 0.00 | 0.00 |
| Feb 16, 2026 | 0.00 | 0.00 | 0.00 |
| Feb 13, 2026 | 0.00 | 0.00 | 0.00 |
| Feb 12, 2026 | 0.00 | 0.00 | 0.00 |
| Feb 11, 2026 | 0.00 | 0.00 | 0.00 |
| Feb 10, 2026 | 0.00 | 0.00 | 7.41 |
| Feb 9, 2026 | 0.00 | 0.00 | 9.65 |
| Feb 6, 2026 | 0.00 | 4.30 | 15.46 |
CANF shares rose +5.20% in Thursday, February 5, 2026's trading session, rising from a previous close of $4.04 to move at $4.25. The stock demonstrated notable intraday movement (see CANF's key stats for a full breakdown), fluctuating between $4.10 and $4.46, a +8.78% trading range. While recent weeks have seen some volatility, CANF has managed to secure a -4.92% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 521.92K shares changing hands, 505.49K more than the previous session. This amounted to $2.22M in total market activity.
Will CANF Continue Its Trend?
According to analyst ratings and projections for CANF, Can-Fite BioPharma Ltd. shares are anticipated to remain stable by -, potentially reaching $0.00 per share by February 19, 2026. Short-term technical indicators for CANF currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the CANF stock forecast, now is not the best time to buy CANF stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on CANF covering social and institutional perspectives.
CANF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CANF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.36% to 50.77%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 37.87%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 39.70%, signals a bearish bias in the long-term trend. Insights into CANF's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Can-Fite BioPharma Short-Term Forecasts
CANF Forecast For Next 5 Days
Our algorithm anticipates Can-Fite BioPharma (CANF) stock could hit $2.58 by Feb 12, 2026. This represents a -39.40% fall from today's price, following a -6.12% change over the past five days.
CANF Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Can-Fite BioPharma Ltd. (CANF) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.25, which would mean a -47.06% decrease from the current price of $4.25. Projections for this period range from a high of $19.86 to a low of $0.00.
CANF Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Can-Fite BioPharma's price over the next three months point to a drop. CANF stock is expected to peak at $35.30 on Mar 12, 2026 before potentially dipping to $0.00 on May 05, 2026. On average, CANF is likely to trade around $4.24 in the coming 90 days.
Can-Fite BioPharma Stock Forecast 2025
Based on our predictive models, Can-Fite BioPharma (CANF) is expected to trade between $0.00 and $39.82 throughout 2026. This would result in an average price of $4.18, potentially offering investors a -1.65% return from current levels.
Can-Fite BioPharma Ltd. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.00 and $31.85, settling at an average of $5.06. This could translate to a +19.06% gain.
March 2026
Based on current market signals, Can-Fite BioPharma Ltd. is projected to trend march 2026. We forecast a trading range from $0.00 to $35.30, with a likely average price of $7.39. Investors could expect a potential return of +73.88%.
April 2026
Our predictive algorithms indicate Can-Fite BioPharma Ltd. stock may see a shift in April 2026. The expected range spans $0.00–$32.15, with an average target of $1.06. This represents a cautious outlook and a possible loss of -75.06%.
May 2026
Analyzing established trends, Can-Fite BioPharma Ltd. looks set to move in May 2026. Projections place the stock between $0.00 and $30.22, averaging around $2.39. This suggests a -43.76% loss from current levels.
June 2026
Market indicators suggest Can-Fite BioPharma Ltd. could experience notable changes during June 2026. Prices could fluctuate within $0.00 to $34.49, with a midpoint forecast of $6.79. The stock might deliver a +59.76% gain.
July 2026
Forecasting for July 2026, models estimate that Can-Fite BioPharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $39.82, averaging $7.94. This signals a positive trajectory with potential returns around +86.82%.
August 2026
According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $30.94, settling at an average of $4.92. This could translate to a +15.76% gain.
September 2026
Based on current market signals, Can-Fite BioPharma Ltd. is projected to trend september 2026. We forecast a trading range from $0.00 to $32.52, with a likely average price of $3.20. Investors could expect a potential return of -24.71%.
October 2026
Our predictive algorithms indicate Can-Fite BioPharma Ltd. stock may see a shift in October 2026. The expected range spans $0.00–$29.93, with an average target of $3.34. This represents a cautious outlook and a possible loss of -21.41%.
November 2026
Analyzing established trends, Can-Fite BioPharma Ltd. looks set to move in November 2026. Projections place the stock between $0.00 and $29.57, averaging around $2.31. This suggests a -45.65% loss from current levels.
December 2026
Market indicators suggest Can-Fite BioPharma Ltd. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $25.29, with a midpoint forecast of $1.66. The stock might deliver a -60.94% loss.
January 2027
Forecasting for January 2027, models estimate that Can-Fite BioPharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $23.56, averaging $1.24. This signals a cautious trajectory with potential returns around -70.82%.
February 2027
According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $26.84, settling at an average of $0.25. This could translate to a -94.12% loss.
CANF's history of dividends and stock splits also plays a role in long-term investor confidence.